510(k) Report

510(k) · Cleared

Cleared

Chemtrue Single / Multi Drug Screen Cassette / Dip Card Tests

K102203510(k) TraditionalCleared Jan 20, 2011169-day reviewClass II21 CFR 862.3100

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Chemtron Biotech, Inc. · DKZ Enzyme Immunoassay, Amphetamine

Cleared on Jan 20, 2011 as substantially equivalent to K020771 (ACON Laboratories, Inc., 2002) after a 169-day review. Its family tree reaches back 1 generation to 2002. 6 later devices descend from it.

Decided
Jan 20, 2011
Review
169 days
Class
Class II
Product code
DKZ
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K020771 (2002). 6 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2012: 1 descendant cleared2014: 1 descendant cleared2015: 4 descendants clearedK020771 · Acon One Step Drug Screen Test Card · ACON Laboratories, Inc. · 2002200020052010201520202025
Descendants, by generation 1 generation forward: 2 descendants2 generations forward: 3 descendants3 generations forward: 1 descendant K020771 · Acon One Step Drug Screen Test Card · ACON Laboratories, Inc. · 20020
  1. Root · 1 generation backK020771 Acon One Step Drug Screen Test CardACON Laboratories, Inc. · 2002
  2. This deviceK102203 Chemtrue Single / Multi Drug Screen Cassette / Dip Card TestsChemtron Biotech, Inc. · 2011
  3. Descendant · cites it directly · 5 of its ownK121339 Chemtrue Single/Multi-Panel Drug Screen Dip Card/Cassette TestsChemtron Biotech, Inc. · 2012
  4. Descendant · cites it directly · 4 of its ownK142580 Chemtrue Multi-Panel DOA DIP Card TestsChemtron Biotech, Inc. · 2014
  5. Descendant · 2 generations on · 1 of its ownK150602 CR3 Keyless Split Sample Cup Morphine - MethamphetamineGuangzhou Wondfo Biotech Co., Ltd. · 2015
  6. Descendant · 2 generations on · 0 of its ownK152643 EGENS Urine Test Cup THC-MDMA, EGENS Urine Test DipCard THC-MDMA…Nantong Egens Biotech Co., Ltd. · 2015
  7. Descendant · 2 generations on · 0 of its ownK151557 EGENS Urine Test Cup Morphine - Methamphetamine, EGENS Urine DipCard…Nantong Egens Biotech Co., Ltd. · 2015

Showing 5 of 6 descendants. See all descendants

Descendants cleared per year

2012: 12014: 12015: 4
2012high 4 (2015) · low 0 (2013)2026

Most influential descendants

Showing 5 of 6 · See all
  • K121339Chemtrue Single/Multi-Panel Drug Screen Dip Card/Cassette TestsChemtron Biotech, Inc. · 2012 · cites it directly5descendants
  • K142580Chemtrue Multi-Panel DOA DIP Card TestsChemtron Biotech, Inc. · 2014 · cites it directly4descendants
  • K150602CR3 Keyless Split Sample Cup Morphine - MethamphetamineGuangzhou Wondfo Biotech Co., Ltd. · 2015 · 2 generations on1descendant
  • K152643EGENS Urine Test Cup THC-MDMA, EGENS Urine Test DipCard THC-MDMA, EGENS Urine Test…Nantong Egens Biotech Co., Ltd. · 2015 · 2 generations on0descendants
  • K151557EGENS Urine Test Cup Morphine - Methamphetamine, EGENS Urine DipCard Morphine -…Nantong Egens Biotech Co., Ltd. · 2015 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K020771Acon One Step Drug Screen Test CardACON Laboratories, Inc.2002—
0 (this device)K102203Chemtrue Single / Multi Drug Screen Cassette / Dip Card TestsChemtron Biotech, Inc.2011—
+1K121339Chemtrue Single/Multi-Panel Drug Screen Dip Card/Cassette TestsChemtron Biotech, Inc.2012—
+1K142580Chemtrue Multi-Panel DOA DIP Card TestsChemtron Biotech, Inc.2014—
+2K150602CR3 Keyless Split Sample Cup Morphine - MethamphetamineGuangzhou Wondfo Biotech Co., Ltd.2015—
+2K152643EGENS Urine Test Cup THC-MDMA, EGENS Urine Test DipCard THC-MDMA, EGENS Urine…Nantong Egens Biotech Co., Ltd.2015—
+2K151557EGENS Urine Test Cup Morphine - Methamphetamine, EGENS Urine DipCard Morphine…Nantong Egens Biotech Co., Ltd.2015—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201210
201410
201540
FIG. 1 — Lineage of K102203, 2002–2015Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DKZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DKZ device

  1. #1 K233019 AllTest Multi-Drug Rapid Test Cup; AllTest…score 14.6 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K020771Acon One Step Drug Screen Test Card
Summary page 2
…510(k) # Amphetamine ACON (INNOVACON) One Step Drug Screen Test Card K(020771 Cocaine ACON (INNOVACON) One Step Drug Screen Test Card K(020771 Methamphetamine ACON…
ACON Laboratories, Inc.2002—

Also cleared against K020771: 8 other devices →

What descends from it? (6)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K121339Chemtrue Single/Multi-Panel Drug Screen Dip Card/Cassette TestsChemtron Biotech, Inc.20125
K142580Chemtrue Multi-Panel DOA DIP Card TestsChemtron Biotech, Inc.20144

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K121339 (Chemtron Biotech, Inc., 2012) has gone furthest, with 5 descendants of its own.
  • 8 other devices also cite its predicate K020771.

How does its category compare?

All DKZ devices

DKZ Enzyme Immunoassay, Amphetamine: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · DKZ

1in 2024

2008: 22009: 22010: 42011: 62012: 52013: 82014: 82015: 52016: 52018: 32019: 32020: 12023: 22024: 1
2007high 8 (2013) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DKZ

180in 2019

2010: 233 days median2011: 123 days median2012: 55 days median2013: 103 days median2014: 128 days median2015: 107 days median2016: 215 days median2018: 128 days median2019: 180 days median
2007high 233 (2010) · low 55 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DKZ

1in 2017

2007: 12008: 32009: 52011: 42013: 12014: 32017: 1
2007high 5 (2009) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DKZ

2in 2025

2008: 122009: 12010: 12011: 22013: 12014: 92015: 82016: 82021: 32022: 42023: 72024: 12025: 2
2007high 12 (2008) · low 0 (2007)2025

MAUDE reports naming product code DKZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—10
20082—312
20092—51
2010423301
2011612342
201255500
2013810311
2014812839
2015510708
2016521508
20170—10
2018312800
2019318000
20201—00
20210—03
20220—04
20232—07
20241—01
20250—02
20260—0—

What is it indicated for?

The Chemitron Biotech, Inc.'s Chemtrue® Single/Multi-Panel Drug Screen Cassette and Dip Card Tests are rapid chromatographic immunoassays for the qualitative detection of up to six of the following drugs in a variety of combinations in human urine. The designed cutoff concentrations and direct calibrator for these drugs are as follows: Analyte — Abbreviation — Calibrator — Cutoff Concentration Amphetamine — AMP — d-Amphetamine — 1000 ng/ml Cocaine — COC…

Read the full statement (216 words)

The Chemitron Biotech, Inc.'s Chemtrue® Single/Multi-Panel Drug Screen Cassette and Dip Card Tests are rapid chromatographic immunoassays for the qualitative detection of up to six of the following drugs in a variety of combinations in human urine. The designed cutoff concentrations and direct calibrator for these drugs are as follows:

Analyte — Abbreviation — Calibrator — Cutoff Concentration

Amphetamine — AMP — d-Amphetamine — 1000 ng/ml

Cocaine — COC — Benzoylecgonine — 300 ng/ml

Marijuana — THC — 11I-oA 9 -THC9-COOH — 50 ng/ml

Methamphetamine — MET — d-Methamphetamine — 1000 ng/ml

Opiates — OPI/MOR — Morphine — 300 ng/ml

Phencyclidine — PCP — Phencyclidine — 25 ng/ml

The Chemtrue® Single/Multi-Panel Drug Screen Cassette and Dip Card are intended for qualitative detection of drugs of abuse for health care professionals, in vitro diagnostic use and prescription use ONLY. It is not intended for point-of-care settings or over the counter use.

This assay provides only a preliminary analytical test result. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. Gas Chromatography / Mass Spectrometry (GC/MS) or Liquid Chromatography / Mass Spectrometry (LC/MS) are the preferred confirmatory methods.

Clinical consideration and professional judgment should be applied to any drugs of abuse test result, particularly when preliminary positive results are indicated.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K102203: Chemtrue Single / Multi Drug Screen Cassette / Dip Card Tests.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K102203

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026